Respiratory Infections

The former FDA commissioner weighs in on the best measures to mitigate skyrocketed new cases, and his timeline for national recovery.

Important finding shows convalescent plasma provides no significant benefit in severe COVID-19 cases.

Recent study shows COVID-19 survivors health improves with support of Home Health Care.

An artificial intelligence (AI) algorithm predicts outcomes in patients diagnosed with COVID-19.

New study provides deep insights into the COVID-19 pandemic.

A recently created therapy for the influenza virus may help aid in the fight against COVID-19.

The guidelines were recently updated to reflect new information on COVID-19 treatment and management.

The influenza therapy is expanded to include people who have been exposed to the flu.

New details of SARS-CoV-2 have been obtained using 3D modeling, providing crucial insights into the disease.

National Institute of Allergy and Infectious Disease (NIAID) has selected Metabolon to participate in a study on this subject.

Study finds that a century-old tuberculosis vaccine could be used in the treatment and prevention of COVID-19.

The third EUA granted to an investigational COVID-19 therapy regimen is indicated for preventing progression from mild, to severe symptoms.

The measles-mumps-rubella (MMR) vaccine could potentially aid in the protection against COVID-19.

Two recent studies conducted by Kansas State University researchers resulted in important findings related to the current COVID-19 pandemic.

Meta-analysis shows people infected with SARS-CoV-2 are more highly infectious within the first week of showing symptoms.

Patients testing positive for SARS-CoV-2 after recovery and negative tests are re-examined to determine if they are reinfected and/or infectious.

Phase 2 results include a large cohort of seniors in the study.

For the first time, prescribed users at suspected risk of COVID-19 can receive rapid results from home.

More than 13 million children did not receive their first DTP vaccine dose in 2019—and investigators anticipate the 2020 rate will be worse.

Phase 2 data hints the immune response-modulating therapy could play a role in burdened hospital settings.

The Vanderbilt Professor of Preventive Medicine shares thoughts on the first potential COVID-19 vaccine, at a time of record new daily cases.

Findings from Michigan show financial, mental health, and cardiopulmonary impacts are prevalent in patients 2 months after hospital care.

The World Health Organization released a brief addressing medical concerns as the influenza season begins in the northern hemisphere during the COVID-19 pandemic.

The new research letter also highlights a concerning rate of infection among Latino patients.

A new survey shows just 2% of children with rheumatic disease reported COVID-19 positive test results or symptoms through early May.